Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals Inc (IMLFF)

Inmed Pharmaceuticals Inc (IMLFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.30
Trade IMLFF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.0400 +60.53%
on 10/15/20
8.9400 -45.41%
on 11/09/20
+1.5300 (+45.67%)
since 10/09/20
3-Month
3.0400 +60.53%
on 10/15/20
8.9400 -45.41%
on 11/09/20
-0.2058 (-4.05%)
since 08/11/20
52-Week
3.0400 +60.53%
on 10/15/20
10.6260 -54.07%
on 01/21/20
-2.5615 (-34.42%)
since 11/11/19

Most Recent Stories

More News
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement Priced At-the-Market under Nasdaq Rules

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
InMed Pharmaceuticals Announces $12 Million Private Placement Priced At-the-Market under Nasdaq Rules

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
InMed Pharmaceuticals to Webcast Live at Life Sciences Investor Forum June 24th

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
Biosynthesis of Cannabinoids Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2020-2027

The Biosynthesis of Cannabinoids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape,...

BMY : 67.87 (-0.41%)
IMLFF : 4.8800 (-1.61%)
InMed Pharmaceuticals Increases Cannabinoid Yield to 5 g/L with IntegraSyn(TM) in Advance of Commercial Scale Production

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
InMed Pharmaceuticals to Present at the 2021 BIO Digital Conference

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of cannabinol...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a clinical-stage company developing pharmaceutical-based drug candidates and leading the way in the clinical development of cannabinol...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM; TSX:IN), a clinical-stage company developing pharmaceutical-based drug candidates and leading the way in the clinical development of cannabinol...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
IN.TO : 4.19 (-1.64%)
InMed to Present at Canaccord Genuity's 5th Annual Global Cannabis Conference on May 11th, 2021

InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM; TSX:IN), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and leading the clinical development of...

IMLFF : 4.8800 (-1.61%)
INM : 2.79 (-2.11%)
IN.TO : 4.19 (-1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 5.6179
1st Resistance Point 5.2489
Last Price 4.8800
1st Support Level 4.2055
2nd Support Level 3.5311
3rd Support Level N/A

See More

52-Week High 10.6260
Fibonacci 61.8% 7.7281
Fibonacci 50% 6.8330
Fibonacci 38.2% 5.9379
Last Price 4.8800
52-Week Low 3.0400

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar